Banner
WorkflowNavbar

First Patient Begins Newly Approved Sickle Cell Gene Therapy

First Patient Begins Newly Approved Sickle Cell Gene Therapy
Contact Counsellor

First Patient Begins Newly Approved Sickle Cell Gene Therapy

  • Commercially approved gene therapy can now cure the condition.

Gene therapy

  • It is a technique that involves altering the genetic material of cells to treat or prevent disease.
  • It aims to introduce a normal, functional gene to compensate for the defective, disease-causing gene.
  • It employs various approaches: replacing a mutated gene with a healthy copy, inactivating a mutated gene, and introducing a new gene.
  • Unlike traditional drugs, gene therapy targets the root genetic causes inside cells.
  • Active clinical trials approach various inherited and acquired disorders.
  • Approaches include ex vivo modification of hematologic stem cells, T lymphocytes, and other immune cells, and in vivo delivery of genes or gene editing reagents to relevant target cells.

Prelims Takeaway:

  • Gene therapy
  • Sickle cell disease

Categories